Trial emulation for validating the clinical efficacy of a foundational AI model in embryo selection.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42026141.
- Also identified by DOI 10.1038/s41746-026-02672-9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
AI models for embryo selection often rely on correlational metrics that ignore clinical confounders. We present a target trial emulation framework to approximate causal effects for a foundational AI model, FEMI, for non-invasive embryo assessment using multi-center trial emulation (n = 4674). Propensity score matching established a robust association between FEMI-Ploidy and implantation failure showing an average treatment effect (ATE) of -0.131 (95% CI [-0.196, -0.066]) in the development cohort and -0.157 (95% CI [-0.254, -0.054]) in the external cohort. Comparative efficacy using S-Learner models demonstrated that a high-risk FEMI score carried a significantly stronger individual treatment effect (ITE) penalty on implantation compared to other scoring mechanisms (p < 0.0001). This superiority persisted after adjusting for maternal age, suggesting FEMI captures unique biological features. This causal framework establishes a rigorous standard for AI validation in IVF, providing the necessary pre-clinical justification for prospective randomized controlled trials.